|
Volumn 101, Issue 8, 2012, Pages 2668-2674
|
Drug delivery trends in clinical trials and translational medicine: Growth in biologic molecule development and impact on rheumatoid arthritis, crohn's disease, and colitis
b
USA
(United States)
|
Author keywords
Biotechnology; Drug interaction; Formulation; Macromolecular drug delivery; Pharmacodynamics; Pharmacokinetics; Physicochemical properties; Prodrugs; Proteins; Targeted drug delivery
|
Indexed keywords
ADALIMUMAB;
AIN 457;
ANRUKINZUMAB;
BEVACIZUMAB;
BIOLOGICAL PRODUCT;
BRODALUMAB;
CCX282 B;
CERTOLIZUMAB PEGOL;
DRUG CARRIER;
ETANERCEPT;
GOLIMUMAB;
INFLIXIMAB;
INSULIN;
INSULIN ASPART;
INSULIN GLARGINE;
INSULIN LISPRO;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
OZORALIZUMAB;
PEGINTERFERON ALPHA2A;
PF 00547659;
PF 04236921;
PRODRUG;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
USTEKINUMAB;
VEDOLIZUMAB;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANEMIA;
BIOLOGICAL THERAPY;
BIOTECHNOLOGY;
BRAIN CANCER;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CENTRAL NERVOUS SYSTEM DISEASE;
CHRONIC LYMPHATIC LEUKEMIA;
COLITIS;
COLLOID;
COLORECTAL CANCER;
COST EFFECTIVENESS ANALYSIS;
CROHN DISEASE;
DEVICES;
DIABETES MELLITUS;
DIGESTIVE SYSTEM DISEASE;
DRUG APPROVAL;
DRUG COST;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG METABOLISM;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TARGETING;
ENDOCRINE DISEASE;
FEBRILE NEUTROPENIA;
FOOD AND DRUG ADMINISTRATION;
HEMOPHILIA A;
HEMOPHILIA B;
HEPATITIS C;
HUMAN;
INFECTION;
INJECTION SITE REACTION;
KIDNEY CANCER;
LUNG CANCER;
MACROMOLECULE;
MEDICAL TECHNOLOGY;
MENTAL DISEASE;
NEOPLASM;
NONHODGKIN LYMPHOMA;
NOTE;
PHARMACODYNAMICS;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PHASE 4 CLINICAL TRIAL (TOPIC);
PSORIASIS;
PSORIATIC ARTHRITIS;
RHEUMATOID ARTHRITIS;
STOMACH CANCER;
TRANSLATIONAL RESEARCH;
UPPER RESPIRATORY TRACT INFECTION;
|
EID: 84862865685
PISSN: 00223549
EISSN: 15206017
Source Type: Journal
DOI: 10.1002/jps.23154 Document Type: Article |
Times cited : (14)
|
References (14)
|